FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3043835340> ?p ?o ?g. }

• W3043835340 endingPage "15" @default.
• W3043835340 startingPage "1" @default.
• W3043835340 abstract "Objective . To analyze the active compounds, potential targets, and diseases of JianPi Fu Recipe (JPFR) based on network pharmacology and bioinformatics and verify the potential biological function and mechanism of JPFR in vitro and in vivo . Methods . Network pharmacology databases including TCMSP, TCM-PTD, TCMID, and DrugBank were used to screen the active compounds and potential drug targets of JPFR. Cytoscape 3.7 software was applied to construct the interaction network between active compounds and potential targets. The DAVID online database analysis was performed to investigate the potential effective diseases and involved signaling pathways according to the results of the GO function and KEGG pathways enrichment analysis. To ensure standardization and maintain interbatch reliability of JPFR, High Performance Liquid Chromatography (HPLC) was used to establish a “chemical fingerprint.” For biological function validation, the effect of JPFR on the proliferation and migration of CRC cells in vitro was investigated by CCK-8 and transwell and wound healing assay, and the effect of JPFR on the growth and metastasis of CRC cells in vivo was detected by building a lung metastasis model in nude mice and in vivo imaging. For the potential mechanism validation, the expressions of MALAT1, PTBP-2, and β -catenin in CRC cells and transplanted CRC tumors were detected by real-time PCR, western blot, and immunohistochemical staining analysis. Results . According to the rules of oral bioavailability (OB) > 30% and drug-likeness (DL) > 0.18, 244 effective compounds in JPFR were screened out, as well as the corresponding 132 potential drug targets. By the analysis of DAVID database, all these key targets were associated closely with the cancer diseases such as prostate cancer, colorectal cancer, bladder cancer, small cell lung cancer, pancreatic cancer, and hepatocellular carcinoma. In addition, multiple signaling pathways were closely related to JPFR, including p53, Wnt, PI3K-Akt, IL-17, HIF-1, p38-MAPK, NF- κ B, PD-L1 expression and PD-1 checkpoint pathway, VEGF, JAK-STAT, and Hippo. The systematical analysis showed that various active compounds of JPFR were closely connected with Wnt/ β -catenin, EGFR, HIF-1, TGF β /Smads, and IL6-STAT3 signaling pathway, including kaempferol, isorhamnetin, calycosin, quercetin, medicarpin, phaseol, spinasterol, hederagenin, beta-sitosterol, wighteone, luteolin, and isotrifoliol. For in vitro experiments, the migration and growth of human CRC cells were inhibited by the JPFR extract in a dose-dependent way, and the expression of MALAT1, PTBP-2, β -catenin, MMP7, c-Myc, and Cyclin D1 in CRC cells were downregulated by the JPFR extract in a dose-dependent way. For in vivo metastasis experiments, the numbers of lung metastasis were found to be decreased by the JPFR extract in a dose-dependent manner, and the expressions of metastasis-associated genes including MALAT1, PTBP-2, β -catenin, and MMP7 in the lung metastases were downregulated dose dependently by the JPFR extract. For the orthotopic transplanted tumor experiments, the JPFR extract could inhibit the growth of orthotopic transplanted tumors and downregulate the expression of c-Myc and Cyclin D1 in a dose-dependent manner. Moreover, the JPFR extract could prolong the survival time of tumor-bearing mice in a dose-dependent manner. Conclusions . Through effective network pharmacology analysis, we found that JPFR contains many effective compounds which may directly target cancer-associated signaling pathways. The in vitro and in vivo experiments further confirmed that JPFR could inhibit the growth and metastasis of CRC cells by regulating β -catenin signaling-associated genes or proteins." @default.
• W3043835340 created "2020-07-29" @default.
• W3043835340 creator A5014048532 @default.
• W3043835340 creator A5031383697 @default.
• W3043835340 creator A5036924064 @default.
• W3043835340 creator A5038858073 @default.
• W3043835340 creator A5050287184 @default.
• W3043835340 creator A5066487510 @default.
• W3043835340 creator A5087467944 @default.
• W3043835340 creator A5090600892 @default.
• W3043835340 date "2020-07-26" @default.
• W3043835340 modified "2023-10-14" @default.
• W3043835340 title "Network Pharmacology Analysis and Experiments Validation of the Inhibitory Effect of JianPi Fu Recipe on Colorectal Cancer LoVo Cells Metastasis and Growth" @default.
• W3043835340 cites W1499157336 @default.
• W3043835340 cites W1918480506 @default.
• W3043835340 cites W1990528489 @default.
• W3043835340 cites W1993352447 @default.
• W3043835340 cites W1994947876 @default.
• W3043835340 cites W2012638782 @default.
• W3043835340 cites W2018518196 @default.
• W3043835340 cites W2027183714 @default.
• W3043835340 cites W2030958001 @default.
• W3043835340 cites W2033591223 @default.
• W3043835340 cites W2035506626 @default.
• W3043835340 cites W2036706062 @default.
• W3043835340 cites W2054106515 @default.
• W3043835340 cites W2104871495 @default.
• W3043835340 cites W2122683221 @default.
• W3043835340 cites W2124679671 @default.
• W3043835340 cites W2124834682 @default.
• W3043835340 cites W2130303892 @default.
• W3043835340 cites W2138844281 @default.
• W3043835340 cites W2158815704 @default.
• W3043835340 cites W2163456090 @default.
• W3043835340 cites W2171507631 @default.
• W3043835340 cites W2345911668 @default.
• W3043835340 cites W2440703170 @default.
• W3043835340 cites W2518563127 @default.
• W3043835340 cites W2560375214 @default.
• W3043835340 cites W2735687500 @default.
• W3043835340 cites W2768054266 @default.
• W3043835340 cites W4249273120 @default.
• W3043835340 doi "https://doi.org/10.1155/2020/4517483" @default.
• W3043835340 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7399765" @default.
• W3043835340 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32774415" @default.
• W3043835340 hasPublicationYear "2020" @default.
• W3043835340 type Work @default.
• W3043835340 sameAs 3043835340 @default.
• W3043835340 citedByCount "11" @default.
• W3043835340 countsByYear W30438353402020 @default.
• W3043835340 countsByYear W30438353402021 @default.
• W3043835340 countsByYear W30438353402022 @default.
• W3043835340 countsByYear W30438353402023 @default.
• W3043835340 crossrefType "journal-article" @default.
• W3043835340 hasAuthorship W3043835340A5014048532 @default.
• W3043835340 hasAuthorship W3043835340A5031383697 @default.
• W3043835340 hasAuthorship W3043835340A5036924064 @default.
• W3043835340 hasAuthorship W3043835340A5038858073 @default.
• W3043835340 hasAuthorship W3043835340A5050287184 @default.
• W3043835340 hasAuthorship W3043835340A5066487510 @default.
• W3043835340 hasAuthorship W3043835340A5087467944 @default.
• W3043835340 hasAuthorship W3043835340A5090600892 @default.
• W3043835340 hasBestOaLocation W30438353401 @default.
• W3043835340 hasConcept C104317684 @default.
• W3043835340 hasConcept C121608353 @default.
• W3043835340 hasConcept C127561419 @default.
• W3043835340 hasConcept C150194340 @default.
• W3043835340 hasConcept C150903083 @default.
• W3043835340 hasConcept C152724338 @default.
• W3043835340 hasConcept C155261790 @default.
• W3043835340 hasConcept C202751555 @default.
• W3043835340 hasConcept C207001950 @default.
• W3043835340 hasConcept C2779013556 @default.
• W3043835340 hasConcept C2779134362 @default.
• W3043835340 hasConcept C2779446555 @default.
• W3043835340 hasConcept C2780035454 @default.
• W3043835340 hasConcept C2987395477 @default.
• W3043835340 hasConcept C502942594 @default.
• W3043835340 hasConcept C526805850 @default.
• W3043835340 hasConcept C54355233 @default.
• W3043835340 hasConcept C55493867 @default.
• W3043835340 hasConcept C62203573 @default.
• W3043835340 hasConcept C70721500 @default.
• W3043835340 hasConcept C86803240 @default.
• W3043835340 hasConcept C98274493 @default.
• W3043835340 hasConceptScore W3043835340C104317684 @default.
• W3043835340 hasConceptScore W3043835340C121608353 @default.
• W3043835340 hasConceptScore W3043835340C127561419 @default.
• W3043835340 hasConceptScore W3043835340C150194340 @default.
• W3043835340 hasConceptScore W3043835340C150903083 @default.
• W3043835340 hasConceptScore W3043835340C152724338 @default.
• W3043835340 hasConceptScore W3043835340C155261790 @default.
• W3043835340 hasConceptScore W3043835340C202751555 @default.
• W3043835340 hasConceptScore W3043835340C207001950 @default.
• W3043835340 hasConceptScore W3043835340C2779013556 @default.
• W3043835340 hasConceptScore W3043835340C2779134362 @default.
• W3043835340 hasConceptScore W3043835340C2779446555 @default.
• W3043835340 hasConceptScore W3043835340C2780035454 @default.

• next